Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
about
Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?Profilin 1 as a target for cathepsin X activity in tumor cellsCalreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses.Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression.Comparison of protein expression profiles of different stages of lymph nodes metastasis in breast cancerCalreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells.miR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells.Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removalRisk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways.Programmed cell removal: a new obstacle in the road to developing cancer.Calreticulin and cancer.Calreticulin gene mutations in myeloproliferative neoplasms without Janus kinase 2 mutations.Calreticulin, a therapeutic target?Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer.Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.Functional roles of calreticulin in cancer biology.Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.Expression and significance of calreticulin in human osteosarcoma.Significance of calreticulin as a prognostic factor in endometrial cancer.
P2860
Q26741412-FE9927F7-3926-4FA5-8DCD-5C198BC3D3D8Q28484945-AABAA563-9FE5-47FE-91A0-AC368921C518Q34555318-DE8C8138-E559-425C-B9F5-4F84B1D97AAEQ35141434-B974FB93-2316-43E1-9265-3738A51D8ECCQ35795318-0B84728F-7815-4C75-8B79-0B985EAC4407Q35996901-5B4DCF03-6E69-421E-BD3C-E79D94222D3FQ36275696-64AA088A-2C69-413C-8E50-F1DC3EE29878Q36413628-D08CECD3-5E8F-4B4E-B79C-A0E1F24379E4Q36738790-0571FB74-5208-4AFD-9A28-4A56535763DAQ37071560-02BDCC3D-BA1E-4DB4-8422-4226A74CD553Q37093956-F596146E-47B7-4AEE-86F6-DA99B827BE59Q37967032-234EBCE5-24FB-473C-9A48-FA6E08AA950CQ38080027-01ACB1FB-3CD5-4B3E-87B5-1127F52F39C6Q38239217-99205D06-AE0C-4142-A690-E86532465951Q38766974-D9DFFF75-92BA-45EA-80CE-649611E05337Q38951772-4AF3C87C-FA69-436D-A740-32A8F80817E7Q39058690-E677E827-68BC-42BD-9C74-CAD0D5926D78Q39607843-A197753F-CE4C-45D4-A142-0407A8BF6EFEQ41147475-C652B909-5629-46DC-9C8A-06D76D2040C0Q47127885-F1D39B38-6E91-4084-9330-1C9B72A7EA07Q51179296-1B87DD82-65CF-484B-B522-2F8DC90DD2DFQ54977789-CD573783-1651-4EC0-99DC-6E659E02F9F3
P2860
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
@en
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
@nl
type
label
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
@en
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
@nl
prefLabel
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
@en
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
@nl
P2093
P2860
P1433
P1476
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma
@en
P2093
Aye Aye Thike
Boon-Huat Bay
Chunhua Guo
George Wai-Cheong Yip
Puay-Hoon Tan
Zin-Mar Lwin
P2860
P2888
P304
P356
10.1038/MODPATHOL.2010.173
P577
2010-09-10T00:00:00Z